» Articles » PMID: 36448277

Biological Characterization, Properties, and Clinical Use of a Novel Homeopathic Antiseptic Oral Recovery Kit: A Narrative Review

Overview
Date 2022 Nov 30
PMID 36448277
Authors
Affiliations
Soon will be listed here.
Abstract

Most available antiseptic solutions have strong antibacterial effects, but many also possess major cytotoxic effects on gingival fibroblasts, osteoblasts, osteoprogenitor cells, and/or epithelial cells. A novel VEGA Oral Care Recovery Kit (StellaLife) consisting of 16 active ingredients that are monographed in the Homeopathic Pharmacopeia of the United States (HPUS) has gained tremendous momentum as a replacement for more cytotoxic oral rinses such as chlorhexidine. While accumulating evidence has thus far supported its use, little of the gathered data have fully described the properties of the oral formulation. Therefore, the aim of the present review article was 3-fold. First, a biological characterization regarding the active ingredients found in StellaLife Recovery Kit including their biological properties was assessed in 4 predominant categories; 1) antimicrobial resistance, 2) accelerated wound healing, 3) pain management control, and 4) anti-cancer properties. The second aim of this review article was to assess both fundamental and clinical research to date comparing VEGA oral rinse (StellaLife) to the more commonly utilized CHX for differences regarding their effect on decreasing bacterial loads as well as cell viability, survival, proliferation, and expression of both regenerative cytokines and inflammatory markers. Lastly, clinical case examples are presented describing the use of StellaLife remedies in a variety of clinical situations. These include but are not limited to wisdom-tooth extraction, extraction site management, dental implants and ridge augmentation, soft-tissue grafting procedures, frenectomies, and also temporary relief of dry sockets, dry mouth, aphthous ulcers, mucositis, lichen planus, among others. In summary, findings from the present review article provide evidence from basic laboratory experiments that validate clinical studies supporting the use of the StellaLife oral rinse regarding its superior biocompatibility and wound healing properties when compared to common antiseptic solutions such as CHX.

References
1.
Sedghi L, DiMassa V, Harrington A, Lynch S, Kapila Y . The oral microbiome: Role of key organisms and complex networks in oral health and disease. Periodontol 2000. 2021; 87(1):107-131. PMC: 8457218. DOI: 10.1111/prd.12393. View

2.
Ortiz M, Fernandez-Martinez E, Soria-Jasso L, Lucas-Gomez I, Villagomez-Ibarra R, Gonzalez-Garcia M . Isolation, identification and molecular docking as cyclooxygenase (COX) inhibitors of the main constituents of Matricaria chamomilla L. extract and its synergistic interaction with diclofenac on nociception and gastric damage in rats. Biomed Pharmacother. 2016; 78:248-256. DOI: 10.1016/j.biopha.2016.01.029. View

3.
Jakubovics N, Goodman S, Mashburn-Warren L, Stafford G, Cieplik F . The dental plaque biofilm matrix. Periodontol 2000. 2021; 86(1):32-56. PMC: 9413593. DOI: 10.1111/prd.12361. View

4.
Sarkar P, Acharyya S, Banerjee A, Patra A, Thankamani K, Koley H . Intracellular, biofilm-inhibitory and membrane-damaging activities of nimbolide isolated from Azadirachta indica A. Juss (Meliaceae) against meticillin-resistant Staphylococcus aureus. J Med Microbiol. 2016; 65(10):1205-1214. DOI: 10.1099/jmm.0.000343. View

5.
Magnani P, Conforti A, Zanolin E, Marzotto M, Bellavite P . Dose-effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice. Psychopharmacology (Berl). 2010; 210(4):533-45. PMC: 2877813. DOI: 10.1007/s00213-010-1855-2. View